Fluidigm and Pacific Biosciences show double-digit gains

Agilent Raises Full-Year Forecast Agilent Technologies continued its solid growth, with fiscal third quarter sales increasing 6.7%, 7.5% organically, to $1.11 billion. The company’s operating profit reached $236 million, an 11.3% increase, whereas its operating margin increased by 90 basis points to 21.2%. The company noted its strong third quarter performance was due to its […]

Asia Pacific exceeds expectations, while Europe indexes decline

Enzo Biochem post gains, while Fluidigm declines

IBO Indexes push forward despite political uncertainties